Study Finds Nanosphere's Gram-Positive Blood Culture Test Reduces Hospital Costs, Treatment Time | GenomeWeb

Using Nanosphere's Gram-Positive Blood Culture microarray test could result in reductions in healthcare costs and lengths of hospital stays, as well as the amount of time it takes for patients with bloodstream infections to receive effective antiobiotic treatment.

A team at the University of Florida Health Jacksonville recently evaluated Nanosphere's BC-GP Test and highlighted its findings in the Journal of Clinical Microbiology.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

This Week in Science: New research into the emergence of infectious diseases, and scientists report on proteins involved in melanoma.

The hashtag #stupidcommonnames is gaining fans among scientists who find the common names of animals and plants dumb.

Fed up with budget slashes, job cuts, and muzzling mandates, researchers in Canada are making science a campaign issue in the upcoming elections.

A former NIH program officer says the Internet has blasted open the door for scientific publications more interested in dollars than quality research.